Stockreport

Agenus’ BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025

Agenus Inc.  (AGEN) 
Last agenus inc. earnings: 3/12 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: agenusbio.com/investors
PDF Durable responses observed in heavily pretreated HCC patients who progressed on approved immunotherapies LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN) [Read more]